Neuren Pharmaceuticals Limited

OTCPK:NURP.F Stock Report

Market Cap: US$1.7b

Neuren Pharmaceuticals Management

Management criteria checks 3/4

Neuren Pharmaceuticals' CEO is Jon Pilcher, appointed in May 2020, has a tenure of 4.17 years. total yearly compensation is A$1.36M, comprised of 40.2% salary and 59.8% bonuses, including company stock and options. directly owns 0.31% of the company’s shares, worth $5.33M. The average tenure of the management team and the board of directors is 4 years and 6 years respectively.

Key information

Jon Pilcher

Chief executive officer

AU$1.4m

Total compensation

CEO salary percentage40.2%
CEO tenure4.2yrs
CEO ownership0.3%
Management average tenure4yrs
Board average tenure6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Jon Pilcher's remuneration changed compared to Neuren Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023AU$1mAU$549k

AU$157m

Sep 30 2023n/an/a

AU$106m

Jun 30 2023n/an/a

AU$55m

Mar 31 2023n/an/a

AU$28m

Dec 31 2022AU$546kAU$396k

AU$184k

Sep 30 2022n/an/a

-AU$3m

Jun 30 2022n/an/a

-AU$7m

Mar 31 2022n/an/a

-AU$7m

Dec 31 2021AU$432kAU$203k

-AU$8m

Compensation vs Market: Jon's total compensation ($USD908.45K) is below average for companies of similar size in the US market ($USD5.63M).

Compensation vs Earnings: Jon's compensation has increased by more than 20% in the past year.


CEO

Jon Pilcher

4.2yrs

Tenure

AU$1,364,404

Compensation

Mr. Jonathan Charles Pilcher, also known as Jon, BSc (Hons), ACA, FCA serves as Managing Director & Executive Director at Neuren Pharmaceuticals Limited since June 14, 2021. He had been a Company Secretary...


Leadership Team

NamePositionTenureCompensationOwnership
Jonathan Pilcher
CEO, MD & Executive Director4.2yrsAU$1.36m0.31%
A$ 5.3m
Lauren Frazer
CFO & Company Secretary3.9yrsno datano data
Lawrence Glass
Chief Science Officer20.5yrsno datano data
Gerry Zhao
Vice President of Corporate Developmentno datano datano data
Liza Squires
Chief Medical Officer2yrsno datano data

4.0yrs

Average Tenure

Experienced Management: NURP.F's management team is considered experienced (4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Jonathan Pilcher
CEO, MD & Executive Director3.1yrsAU$1.36m0.31%
A$ 5.3m
Dianne Angus
Independent Non-Executive Director6yrsAU$75.00k0.023%
A$ 401.5k
Trevor Scott
Independent Non-Executive Director22.3yrsAU$75.00k1.89%
A$ 32.3m
Jenny Harry
Independent Non-Executive Director6yrsAU$75.00k0.023%
A$ 397.0k
Patrick Donald Davies
Independent Non-Executive Chairman6yrsAU$125.00k0.21%
A$ 3.5m
Joe Basile
Independent Non-Executive Director1.3yrsAU$62.50k0.012%
A$ 200.8k

6.0yrs

Average Tenure

Experienced Board: NURP.F's board of directors are considered experienced (6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.